| Traws Pharma, Inc. (TRAW) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | |
| Balance Sheet Date | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | ||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | ||
| Price to Sales | 4.58x | 5.13x | 3.15x | 4.67x | 2.82x | 51.86x | 118.21x | 651.14x | 50.05x | ||||||||||||||||||||||||||||||||||||||||
| Price to Book | - | - | - | 2.92x | .99x | 1.96x | - | - | - | ||||||||||||||||||||||||||||||||||||||||
| Price to Earnings | 2.12x | 2.37x | 1.46x | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||
| Price to Unlevered FCF | - | - | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||
| Debt to Asset Ratio | 1.06x | .63x | .47x | .69x | 2.27x | 1.23x | .67x | .67x | .53x | .46x | .38x | .35x | .28x | .24x | .20x | .18x | .17x | .17x | .26x | .24x | .69x | .52x | .45x | .33x | .51x | 2.01x | 1.53x | 1.14x | .70x | .53x | .47x | 1.80x | 3.18x | 1.69x | .97x | 1.16x | .78x | .64x | .87x | .65x | .54x | .84x | .84x | .66x | .50x | .43x | .34x | ||
| Current Ratio | .72x | 1.22x | 2.09x | 1.81x | 2.16x | 1.07x | 1.88x | 1.93x | 2.46x | 2.79x | 3.51x | 3.80x | 4.89x | 5.96x | 7.44x | 8.64x | 9.06x | 8.53x | 5.89x | 6.64x | 1.97x | 2.69x | 3.20x | 4.61x | 2.83x | .71x | .96x | 1.33x | 2.11x | 2.82x | 3.02x | .81x | .49x | .97x | 1.62x | 1.66x | 2.27x | 3.10x | 1.76x | 2.54x | 3.05x | 2.97x | 2.76x | 3.38x | 4.57x | 4.73x | 6.18x | ||